CO6821955A2 - Derivados de pirazol útiles como inhibidores de aldosterona sintasa - Google Patents

Derivados de pirazol útiles como inhibidores de aldosterona sintasa

Info

Publication number
CO6821955A2
CO6821955A2 CO13290174A CO13290174A CO6821955A2 CO 6821955 A2 CO6821955 A2 CO 6821955A2 CO 13290174 A CO13290174 A CO 13290174A CO 13290174 A CO13290174 A CO 13290174A CO 6821955 A2 CO6821955 A2 CO 6821955A2
Authority
CO
Colombia
Prior art keywords
synthase inhibitors
pyrazole derivatives
derivatives useful
aldosterone synthase
aldosterone
Prior art date
Application number
CO13290174A
Other languages
English (en)
Inventor
Michael Gregory Bell
Paul J Hoogestraat
Thomas Edward Mabry
Quanrong Shen
Ana Maria Escribano
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46317515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6821955(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CO6821955A2 publication Critical patent/CO6821955A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO13290174A 2011-06-14 2013-12-11 Derivados de pirazol útiles como inhibidores de aldosterona sintasa CO6821955A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161496657P 2011-06-14 2011-06-14
US201161506349P 2011-07-11 2011-07-11

Publications (1)

Publication Number Publication Date
CO6821955A2 true CO6821955A2 (es) 2013-12-31

Family

ID=46317515

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13290174A CO6821955A2 (es) 2011-06-14 2013-12-11 Derivados de pirazol útiles como inhibidores de aldosterona sintasa

Country Status (33)

Country Link
US (1) US8778984B2 (es)
EP (1) EP2721009B1 (es)
JP (1) JP5890012B2 (es)
KR (1) KR101555119B1 (es)
CN (1) CN103596930B (es)
AR (1) AR086665A1 (es)
AU (1) AU2012271023A1 (es)
BR (1) BR112013031873A2 (es)
CA (1) CA2836804C (es)
CL (1) CL2013003536A1 (es)
CO (1) CO6821955A2 (es)
CR (1) CR20130601A (es)
CY (1) CY1116687T1 (es)
DK (1) DK2721009T3 (es)
DO (1) DOP2013000284A (es)
EA (1) EA201391655A1 (es)
EC (1) ECSP13013080A (es)
ES (1) ES2548210T3 (es)
GT (1) GT201300307A (es)
HK (1) HK1193103A1 (es)
HR (1) HRP20150939T1 (es)
HU (1) HUE026461T2 (es)
IL (1) IL229485A0 (es)
ME (1) ME02223B (es)
MX (1) MX336042B (es)
PE (1) PE20140606A1 (es)
PL (1) PL2721009T3 (es)
PT (1) PT2721009E (es)
RS (1) RS54269B1 (es)
SG (1) SG194822A1 (es)
SI (1) SI2721009T1 (es)
TW (1) TWI518073B (es)
WO (1) WO2012173849A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110845482B (zh) * 2014-07-04 2024-01-19 日本烟草产业株式会社 制备吲哚化合物的方法
CN108586221B (zh) * 2018-06-26 2021-03-02 常州制药厂有限公司 用于制备替卡格雷的中间体及其制备方法
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57165369A (en) * 1981-04-06 1982-10-12 Teijin Ltd Pyrazole derivative and its preparation
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5057521A (en) * 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
WO2007111175A1 (ja) 2006-03-17 2007-10-04 Ngk Insulators, Ltd. 目封止ハニカム構造体の製造方法
JP5575913B2 (ja) 2009-11-30 2014-08-20 ノバルティス アーゲー アルドステロン合成酵素阻害剤としてのイミダゾール誘導体
SI2523731T1 (sl) 2010-01-14 2019-02-28 Novartis Ag Uporaba sredstva, ki modificira adrenalni hormon

Also Published As

Publication number Publication date
JP2014517034A (ja) 2014-07-17
BR112013031873A2 (pt) 2016-12-13
KR20140009564A (ko) 2014-01-22
CL2013003536A1 (es) 2014-07-11
PL2721009T3 (pl) 2016-01-29
SG194822A1 (en) 2013-12-30
PT2721009E (pt) 2015-10-23
CN103596930A (zh) 2014-02-19
CY1116687T1 (el) 2017-03-15
MX2013014790A (es) 2014-01-24
DOP2013000284A (es) 2014-06-30
HUE026461T2 (en) 2016-05-30
EP2721009B1 (en) 2015-08-12
JP5890012B2 (ja) 2016-03-22
AU2012271023A1 (en) 2013-11-28
SI2721009T1 (sl) 2015-10-30
GT201300307A (es) 2014-11-24
ES2548210T3 (es) 2015-10-14
WO2012173849A1 (en) 2012-12-20
EA201391655A1 (ru) 2014-07-30
IL229485A0 (en) 2014-01-30
AR086665A1 (es) 2014-01-15
MX336042B (es) 2016-01-07
RS54269B1 (en) 2016-02-29
TW201311647A (zh) 2013-03-16
DK2721009T3 (en) 2015-10-26
NZ617642A (en) 2015-11-27
TWI518073B (zh) 2016-01-21
CN103596930B (zh) 2015-05-13
ME02223B (me) 2016-02-20
ECSP13013080A (es) 2014-01-31
KR101555119B1 (ko) 2015-09-22
PE20140606A1 (es) 2014-05-17
CA2836804C (en) 2016-05-24
HK1193103A1 (en) 2014-09-12
US20120322841A1 (en) 2012-12-20
CA2836804A1 (en) 2012-12-20
HRP20150939T1 (en) 2015-10-09
US8778984B2 (en) 2014-07-15
EP2721009A1 (en) 2014-04-23
CR20130601A (es) 2014-05-02

Similar Documents

Publication Publication Date Title
HK1223371A1 (zh) 用作 抑制劑的稠合咪唑衍生物
CO6801747A2 (es) Derivados de pirrolotriazinona como inhibidores de pi3k
CO6831983A2 (es) Compuestos heterocíclicos como inhibidores de cinasas
CO6920291A2 (es) 3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idhmutante
DK2895484T3 (da) Glucosylceramidsynthase-inhibitorer
BRPI1010600A2 (pt) aril piridina como inibidores de aldosterona sintase
CO6880068A2 (es) Aminoquinazolinas como inhibidores de quinasa
ZA201305826B (en) Substituted amminobutyric derivatives as neprilysin inhibitors
CR20130192A (es) Derivados de bencimidazol como inhibidores de cinasa p13
DK3459942T3 (da) DNA-PK-hæmmere
BR112013015449A2 (pt) compostos de bi-heteroarila como inibidores de vps23
BR112013008527A2 (pt) derivados de pirazolo-quinazolina substituídos como inibidores de cinase
CO6862145A2 (es) Imidazopiridazinas como inhibidores de quinasa akt
CO6801764A2 (es) Derivados de pirazol
BR112013013695A2 (pt) derivado de pirazol
EP2701512A4 (en) INHIBITORS OF ALDOSTERONE SYNTHASE
UY33155A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa
EP2870140B8 (en) Tetrahydroquinazolinone derivatives as parp inhibitors
EP2757882A4 (en) IMIDAZOPYRIDYL COMPOUNDS AS AN ALDOSTERONE SYNTHESIS HEMMER
HK1212331A1 (en) 4-carboxamido-isoindolinone derivatives as selective parp-1 inhibitors parp-1 4--
CO7020914A2 (es) Nievos derivados de morofolinilo útiles como inhibidores de mogat-2
EP2861071A4 (en) ALDOSTERONSYNTHASEHEMMER
EP2757883A4 (en) TRIAZOLOPYRIDYL COMPOUNDS FOR USE AS INHIBITORS OF ALDOSTERONE SYNTHASE
HRP20150939T1 (en) Pyrazole derivatives useful as aldosterone synthase inhibitors
HK1211936A1 (en) Dihydroquinoline-2-one derivatives for use as aldosterone synthase inhibitors -2-

Legal Events

Date Code Title Description
FG Application granted